COVID-19
COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2, leading to symptoms such as fever, cough, and difficulty breathing, and can range from mild to severe illness.
Intranasal COVID-19 Vaccine: LVT-001
We are studying a new intranasal booster vaccine for COVID-19 to see if it is safe and more effective than the standard mRNA vaccine. This trial is for healthy adults who want to help improve COVID-19 vaccination strategies.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 60 years old?
- Are you currently pregnant or breastfeeding?
- Have you received at least 3 doses of a COVID-19 mRNA vaccine, with the last dose at least 6 months ago?
- Have you had any serious allergic reactions to vaccines in the past?
- Have you used any illicit drugs in the past 12 months?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Lvt-001
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospices Civils De Lyon
Maladies infectieuses et tropicales
Caluire-et-Cuire, France
Centre Hospitalier Regional Universitaire De Tours
Centre d'Investigation Clinique 1415
La Riche, France
Assistance Publique Hopitaux De Paris
Centre d'Investigation Clinique de Vaccinologie Cochin-Pasteur 1417
Maison Blanche, France
Sponsor: Inserm
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.